Stock-Based Compensation - Additional Information (Detail) (USD $) Share data in Millions, except Per Share data, unless otherwise specified	0 Months Ended	3 Months Ended			9 Months Ended
	Apr. 16, 2015	Jul. 03, 2015	Apr. 03, 2015	Mar. 28, 2014	Apr. 03, 2015	Mar. 28, 2014	Feb. 03, 2015	May 21, 2012
Stock Based Compensation [Abstract]
Expenses on stock-based compensation			$ 17,000,000	$ 24,000,000	$ 53,000,000	$ 69,000,000
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense			8,000,000	6,000,000	20,000,000	17,000,000
Total compensation cost related to unvested stock options and ESPP rights issued			111,000,000		111,000,000
Weighted average service period					2 years 0 months 26 days
Expense related to the vesting of restricted stock unit awards			21,000,000	17,000,000	64,000,000	56,000,000
EmployeeServiceShareBasedCompensationTaxBenefitFromRestrictedStockAmortizationExpense			6,000,000	5,000,000	17,000,000	14,000,000
Unamortized fair value of all unvested restricted stock unit awards			141,000,000		141,000,000
Weighted average vesting period					1 year 6 months 4 days
Compensation cost for cash-settled stock appreciation rights			9,000,000	11,000,000	3,000,000	35,000,000
EmployeeServiceShareBasedCompensationTaxBenefitFromStockAppreciationRightsCompensationExpense			2,000,000	2,000,000	1,000,000	7,000,000
Total liability related to SARs			50,000,000		50,000,000
Options outstanding to purchase shares with exercise price below company stock price			6.4		6.4
Options outstanding to purchase shares with exercise price below company stock price, intrinsic value			358,000,000		358,000,000
Aggregate intrinsic value of options exercised under the Company's stock option plan			73,000,000	60,000,000	236,000,000	164,000,000
Grant-date fair value of the shares underlying the restricted stock awards			8,000,000		124,000,000
Forfeiture rate of restricted stock unit valuation assumption			4.60%		4.40%
Stock Appreciation Right outstanding, weighted average exercise price			$ 8.02		$ 8.02
Number of assumed SARs outstanding			0.6		0.6
Weighted average expected term of the Company's stock options			5 years 3 months 18 days	5 years 7 months 6 days	5 years 9 months 11 days	5 years
StockRepurchaseProgramAdditionalAmountAuthorized							2,000,000,000	3,000,000,000
Treasury Stock, Shares, Acquired			2.2		7.6
Treasury Stock, Value, Acquired, Cost Method			240,000,000		772,000,000
RemainingAmountForRepurchaseUnderShareRepurchaseProgram			2,382,000,000		2,382,000,000
Cash dividend		$ 0.50	$ 0.50		$ 1.30
Payments of Dividends	$ 116,000,000				$ 280,000,000	$ 189,000,000